ranolazine has been researched along with Mitral Stenosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Athauda-Arachchi, P; Lang, C | 1 |
1 other study(ies) available for ranolazine and Mitral Stenosis
| Article | Year |
|---|---|
Metabolic antianginal agent ranolazine offers good symptom relief in a patient with inoperable severe aortic stenosis.
Topics: Acetanilides; Aged, 80 and over; Angina Pectoris; Aortic Valve Stenosis; Cardiovascular Agents; Female; Humans; Mitral Valve Stenosis; Piperazines; Ranolazine; Severity of Illness Index; Treatment Outcome | 2012 |